David Alan Campbell, President and CEO at Janux Therapeutics, Inc. (JANX), sold 8,072 shares at $13.73 ($111K) on 2026-01-02, disclosed to the SEC on 2026-01-02.
Open-market sale of $111k JANX by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| JANX | SELL | 2024-12-03 | $1.0M | — | Filing → |
| JANX | SELL | 2024-11-27 | $2.6M | — | Filing → |
| JANX | SELL | 2024-10-30 | $2.7M | — | Filing → |